全文获取类型
收费全文 | 4915篇 |
免费 | 481篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 50篇 |
儿科学 | 121篇 |
妇产科学 | 143篇 |
基础医学 | 647篇 |
口腔科学 | 53篇 |
临床医学 | 428篇 |
内科学 | 1216篇 |
皮肤病学 | 67篇 |
神经病学 | 386篇 |
特种医学 | 148篇 |
外科学 | 733篇 |
综合类 | 90篇 |
一般理论 | 3篇 |
预防医学 | 265篇 |
眼科学 | 152篇 |
药学 | 335篇 |
中国医学 | 22篇 |
肿瘤学 | 573篇 |
出版年
2023年 | 40篇 |
2022年 | 45篇 |
2021年 | 161篇 |
2020年 | 120篇 |
2019年 | 181篇 |
2018年 | 166篇 |
2017年 | 131篇 |
2016年 | 141篇 |
2015年 | 186篇 |
2014年 | 214篇 |
2013年 | 240篇 |
2012年 | 349篇 |
2011年 | 352篇 |
2010年 | 205篇 |
2009年 | 170篇 |
2008年 | 270篇 |
2007年 | 270篇 |
2006年 | 252篇 |
2005年 | 227篇 |
2004年 | 206篇 |
2003年 | 202篇 |
2002年 | 173篇 |
2001年 | 110篇 |
2000年 | 115篇 |
1999年 | 80篇 |
1998年 | 41篇 |
1997年 | 27篇 |
1996年 | 30篇 |
1995年 | 20篇 |
1994年 | 24篇 |
1993年 | 24篇 |
1992年 | 61篇 |
1991年 | 59篇 |
1990年 | 76篇 |
1989年 | 49篇 |
1988年 | 51篇 |
1987年 | 53篇 |
1986年 | 38篇 |
1985年 | 48篇 |
1984年 | 35篇 |
1983年 | 25篇 |
1982年 | 16篇 |
1981年 | 17篇 |
1980年 | 16篇 |
1979年 | 17篇 |
1978年 | 17篇 |
1977年 | 11篇 |
1976年 | 14篇 |
1974年 | 10篇 |
1973年 | 9篇 |
排序方式: 共有5432条查询结果,搜索用时 78 毫秒
91.
Hon Mei Yee Chua Xin Yun Premakumar Chandini Menon Mohamed Shah Noraida 《International journal of clinical pharmacy》2020,42(3):948-955
International Journal of Clinical Pharmacy - Background Drug-related problems are relatively common among hospitalised patients and may be detrimental to patients and even increase healthcare... 相似文献
92.
The proteome of Naja sumatrana (Equatorial spitting cobra) venom was investigated by shotgun analysis and a combination of ion-exchange chromatography and reverse phase HPLC. Shotgun analysis revealed the presence of 39 proteins in the venom while the chromatographic approach identified 37 venom proteins. The results indicated that, like other Asiatic cobra venoms, N. sumatrana contains large number of three finger toxins and phospholipases A2, which together constitute 92.1% by weight of venom protein. However, only eight of the toxins can be considered as major venom toxins. These include two phospholipases A2, three neurotoxins (two long neurotoxins and a short neurotoxin) and three cardiotoxins. The eight major toxins have relative abundance of 1.6–27.2% venom proteins and together account for 89.8% (by weight) of total venom protein. Other venom proteins identified include Zn-metalloproteinase-disintegrin, Thaicobrin, CRISP, natriuretic peptide, complement depleting factors, cobra venom factors, venom nerve growth factor and cobra serum albumin. The proteome of N. sumatrana venom is similar to proteome of other Asiatic cobra venoms but differs from that of African spitting cobra venom. Our results confirm that the main toxic action of N. sumatrana venom is neurotoxic but the large amount of cardiotoxins and phospholipases A2 are likely to contribute significantly to the overall pathophysiological action of the venom. The differences in toxin distribution between N. sumatrana venom and African spitting cobra venoms suggest possible differences in the pathophysiological actions of N. sumatrana venom and the African spitting cobra venoms, and explain why antivenom raised against Asiatic cobra venom is not effective against African spitting cobra venoms. 相似文献
93.
Jan Kottner Janet Cuddigan Keryln Carville Katrin Balzer Dan Berlowitz Susan Law Mary Litchford Pamela Mitchell Zena Moore Joyce Pittman Dominique Sigaudo-Roussel Chang Yee Yee Emily Haesler 《Journal of tissue viability》2019,28(2):51-58
Aim
The European Pressure Ulcer Advisory Panel, the Pan Pacific Pressure Injury Alliance, and the National Pressure Ulcer Advisory Panel are updating the ‘Prevention and Treatment of Pressure Ulcers: Clinical Practice Guideline’ (CPG) in 2019. The aim of this contribution is to summarize and to discuss the guideline development protocol for the 2019 update.Methods
A guideline governance group determines and monitors all steps of the CPG development. An international survey of consumers will be undertaken to establish consumer needs and interests. Systematic evidence searches in relevant electronic databases cover the period from July 2013 through August 2018. Risk of bias of included studies will be assessed by two reviewers using established checklists and an overall strength of evidence assigned to the cumulative body of evidence. Small working groups review the evidence available for each topic, review and/or draft the guideline chapters and recommendations and/or good practice statements. Finally, strength of recommendation grades are assigned. The recommendations are rated based on their importance and their potential to improve individual patient outcomes using an international formal consensus process.Discussion
Major methodological advantages of the current revision are a clear distinction between evidence-based recommendations and good practice statements and strong consumer involvement.Conclusion
The 2019 guideline update builds on the previous 2014 version to ensure consistency and comparability. Methodology changes will improve the guideline quality to increase clarity and to enhance implementation and compliance. The full guideline development protocol can be accessed from the guideline website (http://www.internationalguideline.com/). 相似文献94.
95.
96.
Grace C. Lee Hansheng Liou Russell Yee Clifford F. Quan Katherine Neldner 《Clinical therapeutics》2012,34(12):2297-2300
Studies evaluating the outcomes of an extended-infusion (EI) piperacillin-tazobactam dosing strategy in specific cohorts of critically ill patients are lacking. A retrospective, pre-implementation and post-implementation study of 148 critically ill patients was conducted to compare EI and traditional infusion piperacillin-tazobactam. In this retrospective study, the EI piperacillin-tazobactam dosing strategy was associated with improved 30-day mortality. EI piperacillin-tazobactam may be an effective alternative to TI of piperacillin-tazobactam among critically ill patients treated for suspected gram-negative infections. 相似文献
97.
Byung Woog Kang Jong Gwang Kim Yee Soo Chae Han Ik Bae Ohkyoung Kwon Ho Young Chung Wansik Yu Hong Suk Song Yu Na Kang Seung Wan Ryu Kyung Hee Lee Young Kyung Bae Joon Hyuk Choi Se Won Kim Hun‐Mo Ryoo Chang‐Ho Cho Hyun‐Dong Chae Kyun Woo Park Mi Jin Gu Byung‐Jo Bae 《Asia-Pacific Journal of Clinical Oncology》2014,10(2):e40-e45
98.
99.
100.
Janice L. Y. Mong Maggie C. Y. Ng Georgia S. Guldan Claudia H. T. Tam Heung Man Lee Ronald C. W. Ma Wing Yee So Gary W. K. Wong Alice P. S. Kong Juliana C. N. Chan Mary M. Y. Waye 《Clinical endocrinology》2010,73(3):313-322
Objective: To explore the genetic effect of the GH receptor (GHR) on obesity and related metabolic parameters in Hong Kong Chinese adolescents. Context: Obesity is a growing global epidemic. Increasing evidence suggests that the GH‐IGF‐I axis plays an important role in regulating adiposity and insulin sensitivity. Design: We examined the associations of genetic variants of GHR with serum IGF‐I and IGFBP‐3 levels as well as obesity‐related metabolic traits in Hong Kong Chinese adolescents. Patients: Nine hundred and eighty‐one randomly selected Hong Kong Chinese adolescents from 14 schools. Measurements: We genotyped 17 single nucleotide polymorphisms (SNP) at GHR and measured serum IGF‐I and IGFBP‐3 levels as well as obesity‐related metabolic traits including fasting plasma glucose, insulin and lipid levels. Results: There were significant associations between rs4410646 and the body composition (P = 0·0044) and blood pressure factor scores (P = 0·00017). Carriers of the CC genotype had lower body mass index, percentage body fat, waist and hip circumferences than AC and AA genotype carriers (P = 0·00030–0·0094). There was also association between rs7703713 and the IGF‐I activity factor score (P = 0·0033). The GA and AA carriers of rs7703713 had higher serum IGF‐I, higher serum IGFBP‐3 and higher IGF‐I/IGFBP‐3 molar ratio (P = 0·00069–0·025). Haplotype analysis did not increase the significance of associations. Conclusion: Our results support the role of GHR gene polymorphisms in modulating adiposity and IGF‐I activity in adolescents. Examination of interactions of these SNPs with lifestyle, environmental and perinatal factors may provide further insights into their long‐term effects on obesity and metabolic risks. 相似文献